Evercore ISI analyst Vijay Kumar upgraded iRhythm (IRTC) to Outperform from In Line with a price target of $210, up from $194.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IRTC:
- iRhythm price target lowered to $215 from $230 at Truist
- iRhythm price target lowered to $220 from $235 at Baird
- iRhythm price target raised to $205 from $195 at Morgan Stanley
- iRhythm presents new data on Zio long-term continuous ECG monitoring
- Confident Buy Rating for Irhythm Technologies Amidst LCD Concerns and Market Expansion Opportunities